The use of smartwatches in detecting congestive heart failure could revolutionize early diagnosis and treatment, offering a promising tool for patients and health care providers alike.

Congestive heart failure affects 26 million people worldwide and is a leading cause of death globally, often striking with warning signs that go unnoticed.

Symptoms of congestive heart failure include chest pain, shortness of breath, weight gain, and a persistent cough or wheezing. Despite these indicators, many people fail to recognize them until the condition becomes severe.

Current detection methods for congestive heart failure include blood tests, X-rays, stress tests, CT scans, and ECGs.

A study by the Heart Rhythm Society suggests that smartwatches could offer a new method of detection. The study found that by using ECG information, researchers achieved a 90% success rate in identifying congestive heart failure, potentially allowing for earlier intervention.

While smartwatches have already been proven to detect atrial fibrillation, a medical professional should interpret the information that the devices capture.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.